featured
Cardiovascular Outcomes of Evening vs Morning Dosing of Antihypertensives
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial
Lancet 2022 Oct 22;400(10361)1417-1425, IS Mackenzie, A Rogers, NR Poulter, B Williams, MJ Brown, DJ Webb, I Ford, DA Rorie, G Guthrie, JWK Grieve, F Pigazzani, PM Rothwell, R Young, A McConnachie, AD Struthers, CC Lang, TM MacDonaldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.